The pathogenesis of congenital malformations in diabetic pregnancy
1995; Wiley; Volume: 11; Issue: 1 Linguagem: Inglês
10.1002/dmr.5610110106
ISSN1099-0895
Autores Tópico(s)Prenatal Screening and Diagnostics
ResumoDiabetes/Metabolism ReviewsVolume 11, Issue 1 p. 63-82 Article The pathogenesis of congenital malformations in diabetic pregnancy Ulf J. Eriksson, Corresponding Author Ulf J. Eriksson Department of Medical Cell Biology, University of Uppsala, Uppsala, SwedenUlf J. Eriksson, Dept of Medical Cell Biology, University of Uppsala, Biomedicum, P.O. Box 571, S-751 23 Uppsala, SwedenSearch for more papers by this author Ulf J. Eriksson, Corresponding Author Ulf J. Eriksson Department of Medical Cell Biology, University of Uppsala, Uppsala, SwedenUlf J. Eriksson, Dept of Medical Cell Biology, University of Uppsala, Biomedicum, P.O. Box 571, S-751 23 Uppsala, SwedenSearch for more papers by this author First published: April 1995 https://doi.org/10.1002/dmr.5610110106Citations: 28AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Pedersen J: The Pregnant Diabetic and her Newborn. Problems and Management, 2nd ed. Munksgaard, Copenhagen, 1977. 2 Eriksson UJ: Congenital malformations in diabetic animal models—a review. Diabetes Res 1: 57–66, 1984. 3 Mills JL: Malformations in infants of diabetic mothers. Teratology 25: 385–394, 1982. 4 Freinkel N: Diabetic embryopathy and fuel-mediated organ teratogenesis: lessons from animal models. Horm Metab Res 20: 463–475, 1988. 5 Baker L and Piddington R: Diabetic embryopathy: a selective review of recent trends. J Diabetes Complications 7: 204–212, 1993. 6 Kucera J: Rate and type of congenital anomalies among offspring of diabetic women. J Reprod Med 7: 61–70, 1971. 7 Karlsson K, and Kjellmer I: The outcome of diabetic pregnancies in relation to the mother's blood sugar level. Am J Obstet Gynecol 112: 213–230, 1972. 8 White P: Diabetes mellitus in pregnancy. Clin Perinatol 1: 331–338, 1974. 9 Chung CS, and Myrianthopoulos NC: Factors affecting risks of congenital malformations. II. Effect of maternal diabetes on congenital malformations. Birth Defects 11: 23–38, 1975. 10 Gabbe SG, Mestman JH, Freeman RK, Goebelsmann UT, Lowensohn RI, Nochimson D, Citrulo C, and Quilligan EJ: Management and outcome of pregnancy in diabetes mellitus classes B to R. Am J Obstet Gynecol 129: 723–732, 1977. 11 Kitzmiller JL, Cloherty JP, Younger MD, Tabatabaff A, Rothchild SB, Sosenko I, Epstein MF, Singh S and Neff RK: Diabetic pregnancy and perinatal morbidity. Am J Obstet Gynecol 131: 560–580, 1978. 12 Olofsson P, Liedholm H, Sartor G, Sjöberg NO, Svenningsen NW, and Ursing D: Diabetes and pregnancy. A 21-year Swedish material. Acta Obstet Gynecol Scand Suppl 122: 1–62, 1984. 13 Olofsson P, Sjöberg NO, Solum T, and Svenningsen NW: Changing panorama of perinatal and infant mortality in diabetic pregnancy. Acta Obstet Gynecol Scand 63: 467–472, 1984. 14 Hadden DR: Diabetes in pregnancy 1985. Clinical controversy. Diabetologia 29: 1–9, 1986. 15 Duncan JM: On puerperal diabetes. Trans Obstet Soc London 24: 256–285, 1882. 16 Drury MI, Green AT, and Stronge JM: Pregnancy complicated by clinical diabetes mellitus: a study of 600 pregnancies. Am J Obstet Gynecol 49: 519–522, 1977. 17 Simpson JL, Elias S, Martin AO, Palmers MS, Ogata ES, and Radvany RA: Diabetes in pregnancy, Northwestern University series (1977–1981). I. Prospective study of anomalies in offspring of mothers with diabetes mellitus. Am J Obstet Gynecol 146: 263–270, 1983. 18 Mølsted-Pedersen L, and Kühl C: Obstetrical management in diabetic pregnancy: the Copenhagen experience. Diabetologia 29: 13–16, 1986. 19 Becerra JE, Khoury MJ, Cordero JF, and Erickson JD.: Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case–control study. Pediatrics 85: 1–9, 1990. 20 Hanson U, Persson B, and Thunell S: Relationship between haemoglobin A1c in early type 1 (insulin-dependent) diabetic pregnancy and the occurrence of spontaneous abortion and fetal malformation in Sweden. Diabetologia 33: 100–104, 1990. 21 Kitzmiller JL, Gavin LA, Gin GD, Jovanovic-Peterson L, Main EK, and Zigrang WD: Preconception care of diabetes. Glycemic control prevents congenital anomalies. J Am Med Assoc 265: 731–736, 1991. 22 Kim JN, Runge W, Wells LJ, and Lazarow A: Effects of experimental diabetes on the offspring of the rat. Fetal growth, birth, weight, gestation period and fetal mortality. Diabetes 9: 396–404, 1960. 23 Horii K, Watanabe G, and Ingalls TH: Experimental diabetes in pregnant mice: prevention of congenital malformations in offspring by insulin. Diabetes 15: 194–204, 1966. 24 Endo A: Teratogenesis in diabetic mice treated with alloxan prior to conception. Arch Environ Health 12: 492–500, 1966. 25 Baker L, Egler JM, Klein SM, and Goldman AS: Meticulous control of diabetes during organogenesis prevents congenital lumbrosacral defects in rats. Diabetes 30: 955–959, 1981. 26 Eriksson UJ, Dahlström E, Larsson KS, and Hellerström C: Increased incidence of congenital malformations in the offspring of diabetic rats and their prevention by maternal insulin therapy. Diabetes 31: 1–6, 1982. 27 Brownscheidle M, Wootten V, Mathieu MH, Davis DL, and Hofman IA: The effects of maternal diabetes on fetal maturation and neonatal health. Metabolism 32 (Suppl 1): 148–155, 1983. 28 Eriksson UJ, Lewis NJ, and Freinkel N: Growth retardation during early organogenesis in embryos of experimentally diabetic rats. Diabetes 33: 281–284, 1984. 29 Eriksson UJ: Diabetes in pregnancy: retarded fetal growth, congenital malformations and feto-maternal concentrations of zinc, copper and manganese in the rat. J Nutr 114: 477–486, 1984. 30 Uriu-Hare JY, Stern JS, Reaven GM, and Keen CL: The effect of maternal diabetes on trace element status and fetal development in the rat. Diabetes 34: 1031–1040, 1985. 31 Giavini E, Brocca ML, Prati M, Roversi GD, and Vismara C: Effects of streptozotocin-induced diabetes on fetal development of the rat. Teratology 34: 81–88, 1986. 32 Zusman J, Yaffe P, and Ornoy A: The effects of high-sucrose diets and of maternal diabetes on the ultrastructure of the visceral yolk sac endoderm in rat embryos developing in vivo and in vitro. Acta Anat 128: 11–18, 1987. 33 Eriksson UJ, Bone AJ, Turnbull DM, and Baird JD: Timed interruption of insulin therapy in diabetic BB/E rat pregnancy: effects on maternal metabolism and fetal outcome. Acta Endocrinol (Copenhagen) 120: 800–810, 1989. 34 Palumbo G, Fagone S, Foddai B, Russo I, and Rugolo S: Detection of late fetal and neonatal malformations in infants of diabetic mothers. Diabetes Nutr Metab 3 (Suppl 2): 79–80, 1990. 35 Giavini E, Brocca ML, Prati M, Roversi GD, and Vismara C: Cataractogenic effects of streptozotocin-induced diabetes in rat fetuses. Acta Embryol Morphol Exp 8: 481–486, 1987. 36 Giavini E, and Prati M: Morphogenesis of diabetes-induced congenital cataract in the rat. Acta Anat 137: 132–136, 1990. 37 Simán CM, Naeser P, and Eriksson UJ: Increased lenticular aldose reductase activity and high incidence of congenital cataract in the offspring of diabetic rats. Acta Ophthalmol 71: 629–636, 1993. 38 Danielsson K, Simán M, Danielsson B, Naeser P, and Eriksson UJ: Diabetes-induced teratological changes in the offspring of a malformation-prone rat strain. In preparation. 39 Mølsted-Pedersen L, Tygstrups I, and Pedersen J: Congenital malformations in newborn infants of diabetic women: correlation with maternal diabetic vascular complications. Lancet i: 1124–1126, 1964. 40 Rowland TW, Hubbell JP, and Nadas AS: Congenital heart disease in infants of diabetic mothers. J Pediatr 83: 815–820, 1973. 41 Reece EA, and Hobbins JC: Diabetic embryopathy: pathogenesis, prenatal diagnosis and prevention. Obstet Gynecol Surv 41: 325–335, 1986. 42 Eriksson RSM, Thunberg L, and Eriksson UJ: Effects of interrupted insulin treatment on fetal outcome of pregnant diabetic rats. Diabetes 38: 764–772, 1989. 43 Churchill JA, Berendes HW, and Nemore J: Neuro-psychological deficit in children of diabetic mothers. Am J Obstet Gynecol 105: 257–268, 1969. 44 Bibergeil H, Gödel E, and Amendt P: Diabetes and pregnancy: early and late prognosis of children of diabetic mothers. In Early Diabetes in Early Life, RA Camerini-Davalos and HS Cole, Eds. Academic Press, New York, 1975, pp 427–434. 45 Yssing M: Long-term prognosis of children born to mothers diabetic when pregnant. In Early Diabetes in Early Life, RA Camerini-Davalos, and HS Cole, Eds. Academic Press, New York, 1975, pp 575–586. 46 Haworth JC, McRae KN, and Dilling LA: Prognosis of infants of diabetic mothers in relation to neonatal hypoglycemia. Dev Med Child Neurol 18: 471–479, 1976. 47 Stehbens JA, Baker GL, and Kitchell M: Outcome at ages 1, 3 and 5 years of children born to diabetic women. Am J Obstet Gynecol 127: 408–413, 1977. 48 Petersen MB, Pedersen SA, Greisen G, Pedersen JF, and Mølsted-Pedersen L: Early growth delay in diabetic pregnancy: relation to psychomotor development at age 4. Br Med J 296: 598–600, 1988. 49 Rizzo T, Freinkel N, Metzger BE, Hatcher R, Burns WJ, and Barglow P: Correlations between antepartum maternal metabolism and newborn behaviour. Am J Obstet Gynecol 163: 1458–1464, 1990. 50 Cummins M, and Norrish M: Follow-up of children of diabetic mothers. Arch Dis Child 55: 259–264, 1980. 51 Hadden DR, Byrne E, Trotter I, Harley JM, McClure G, and McAuley RR: Physical and psychological health of children of type 1 (insulin-dependent) diabetic mothers. Diabetologia 26: 250–254, 1984. 52 Persson B, and Gentz J: Follow-up of children of insulin-dependent and gestational diabetic mothers: neuropsychological outcome. Acta Paediatr Scand 73: 349–358, 1984. 53 Persson B: Long-term morbidity in infants of diabetic mothers. Acta Endocrinol (Copenhagen) Suppl 277: 156–158, 1986. 54 Rizzo T, Metzger BE, Burns WJ and Burns K: Correlations between antepartum maternal metabolism and child intelligence. N Engl J Med 325: 911–916, 1991. 55 Silverman BL, Rizzo T, Green OC, Cho NH, Winter RJ, Ogata ES, Richards GE, and Metzger BE: Long-term prospective evaluation of offspring of diabetic mothers. Diabetes 40 (Suppl 2): 121–125, 1991. 56 Johansson B, Meyerson B, and Eriksson UJ: Behavioural effects of an intrauterine or neonatal diabetic environment in the rat. Biol Neonate 59: 226–235, 1991. 57 Mills J, Baker L, and Goldman AS: Malformations in infants of diabetic mothers occur before the seventh gestational week. Diabetes 28: 292–293, 1979. 58 Diamond MP, Moley KH, Pellicer A, Vaughn WK, and DeCherney AH: Effects of streptozotocin- and alloxan-induced diabetes mellitus on mouse follicular and early embryo development. J Reprod Fertil 86: 1–10, 1989. 59 Pampfer S, De Hertogh R, Vanderheyden I, Michiels B, and Vercheval M: Decreased inner cell mass proportion in blastocysts from diabetic rats. Diabetes 39: 471–476, 1990. 60 Leslie RDG, Pyke DA, John PN, and White JM: Hemoglobin A1 in diabetic pregnancy. Lancet ii: 958–959, 1978. 61 Miller E, Hare JW, Cloherty JP, Dunn PJ, Gleason RE, Soeldner JS, and Kitzmiller JL: Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 304: 1331–1334, 1981. 62 Ylinen K, Aula P, Stenman U-H, Kesäniemi-Kuokkanen T, and Teramo K: Risk of minor and major fetal malformations in diabetics with high hemoglobin A1c values in early pregnancy. Br Med J 289: 345–346, 1984. 63 Greene MF, Hare JW, Cloherty JP, Benacerraf BR, and Soeldner JS: First-trimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology 39: 225–231, 1989. 64 Freinkel N, Cockroft DL, Lewis NJ, Gorman L, Akazawa S, Phillips LS, and Shambaugh GE III: Fuel-mediated teratogenesis during early organogenesis: the effects of increased concentrations of glucose, ketones, or somatomedin inhibitor during rat embryo culture. Am J Clin Nutr 44: 986–995, 1986. 65 Sadler TW, Hunter ES III, Wynn RE, and Phillips LS: Evidence for multifactorial origin of diabetes-induced embryopathies. Diabetes 38: 70–74, 1989. 66 Styrud J, Thunberg L, Nybacka O, and Eriksson UJ: Correlations between maternal metabolism and deranged development in the offspring of normal and diabetic rats. Pediatr Res 37: 343–353, 1995. 67 Mills JL, Knopp RH, Simpson JL, Jovanovic-Peterson L, Metzger BE, Holmes LB, Aarons JH, Brown Z, Reed GF, Bieber FR, Van Allen M, Holzman I, Ober C, Peterson CM, Withiam MJ, Duckles A, Mueller-Heubach E, and Polk BF, and the National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study: Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. N Engl J Med 318: 671–676, 1988. 68 Mills J, Simpson J, Driscoll SG, Jovanovic-Peterson L, Van Allen M, Aarons JH, Metzger BE, Bieber FR, Knopp RH, Holmes LB, Peterson CM, Withiam-Wilson M, Brown Z, Ober C, Harley E, MacPherson TA, Duckles A, Mueller-Heubach E, and the National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study: Incidence of spontaneous abortion among normal women and insulin dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med 319: 1617–1623, 1988. 69 Buchanan TA, Denno KM, Sipos GF, and Sadler TW: Diabetic teratogenesis: in vitro evidence for a multifactorial etiology with little contribution from glucose per se. Diabetes 43: 656–660, 1994. 70 Fuhrmann K, Reiher H, Semmler K, and Glöckner E: The effect of intensified conventional insulin therapy before and during pregnancy on the malformation rate in offspring of diabetic mothers. Exp Clin Endocrinol 83: 173–177, 1984. 71 Eriksson UJ: Importance of genetic predisposition and maternal environment for the occurrence of congenital malformations in offspring of diabetic rats. Teratology 37: 365–374, 1988. 72 Bender K, Adams M, Baverstock PR, den Bieman M, Bissbort S, Brdicka R, Butcher GW, Cramer DV, von Deimling O, Festing MFW, Günther E, Guttmann RD, Hedrich HJ, Kendall PB, Kluge R, Moutier R, Simon B, Womack JE, Yamada J, and van Zutphen B: Biochemical markers in inbred strains of the rat (Rattus norvegicus). Immunogenetics 19: 257–266, 1984. 73 Eriksson UJ, den Bieman M, Prins JB, and van Zutphen LFM: Differences in susceptibility for diabetes induced malformations in separated rat colonies of common origin. In Proceedings of the 4th FELASA Symposium, Lyon, France, 1990, pp. 53–57. 74 Comess LJ, Bennett PH, Burch TA, and Miller M: Congenital anomalies and diabetes in the Pima Indians of Arizona. Diabetes 18: 471–477, 1969. 75 Weigensberg M, Sobel R, Garcia-Palmer F, and Freinkel N: Temporal differences in vulnerability to "fuel-mediated teratogenesis". Diabetes 38 (Suppl 1): 85A, 1989 (Abstract). 76 New DAT: Whole-embryo culture and the study of mammalian embryos during organogenesis. Biol Rev 53: 81–122, 1978. 77 Freinkel N: Of pregnancy and progeny. Diabetes 29: 1023–1035, 1980. 78 Lasunción MA, Lorenzo J, Palacin M, and Herrera E: Maternal factors modulating nutrient transfer to fetus. Biol Neonate 51: 86–93, 1987. 79 Thomas CR, Eriksson GL, and Eriksson UJ: Effects of maternal diabetes on placental transfer of glucose in rats. Diabetes 39: 276–282, 1990. 80 Thomas CR: Placental transfer of non-esterified fatty acids in normal and diabetic pregnancy. Biol Neonate 51: 94–101, 1987. 81 Nylund L, Lunell NO, Sarby B, Lewander R, and Thornström S: Functional placental scintigraphy: a methodological and clinical investigation. Acta Radiol (Diagn) (Stockholm), 24: 165–170, 1983. 82 Skjöldebrand A, Jansson T, Kjellmer I, Lunell NO, Nylund L, Sarby B, and Thornström S: Comparison between measurements of maternal placental blood flow with dynamic placental scintigraphy and radioactive microspheres. Placenta 10: 95–102, 1989. 83 Käär K, Jouppila P, Kuikka J, Luotola H, Toivonen J, and Rekonen A: Intervillous blood flow in normal and complicated late pregnancy measured by means of an intravenous 133Xc method. Acta Obstet Gynecol Scand 59: 7–10, 1980. 84 Nylund L, Lunell NO, Lewander R, Persson B, and Sarby B: Uteroplacental blood flow in diabetic pregnancy: measurements with indium 113m and a computer linked gamma camera. Am J Obstet Gynecol 144: 298–302, 1982. 85 Semmler K, Kirsch G, Zöllner P, Fuhrmann K, and Jutzi E: Die Messung der uteroplazentaren Durchblutung mit Indium-113m in der diabetischen Schwangerschaft. Zentralbl Gynakol 107: 793–802, 1985. 86 Eriksson UJ, and Jansson L: Diabetes in pregnancy: decreased placental blood flow and disturbed fetal development in the rat. Pediatr Res 18: 735–738, 1984. 87 Palacin M, Lasunción MA, Martin A, and Herrera E: Decreased uterine blood flow in the diabetic pregnant rat does not modify the augmented glucose transfer to the fetus. Biol Neonate 48: 197–203, 1985. 88 Chartrel NC, Clabaut MT, Boismare FA, and Schrub J-C: Uteroplacental hemodynamic disturbances in establishment of fetal growth retardation in streptozotocin-induced diabetic rats. Diabetes 39: 743–746, 1990. 89 Wentzel P, Jansson L, and Eriksson UJ: Diabetes in pregnancy: uterine blood flow and embryonic development in the rat. In preparation. 90 Ornoy A, Zusman J, Cohen AM, and Shafrir E: Effects of sera from Cohen, genetically determined diabetic rats, streptozotocin diabetic rats and sucrose fed rats on in vitro development of early somite rat embryos. Diabetes Res 3: 43–51, 1986. 91 Pinter E, Reece EA, Leranth CS, Sanyal MK, Hobbins JC, Mahoney MJ, and Naftolin F: Yolk sac failure in embryopathy due to hyperglycemia: ultrastructural analysis of yolk sac differentiation associated with embryopathy in rat conceptuses under hyperglycemic conditions. Teratology 33: 73–84, 1986. 92 Sussman I, and Matschinsky FM: Diabetes affects sorbitol and myo-inositol levels of neuroectodermal tissue during embryogenesis in rat. Diabetes 37: 974–981, 1988. 93 Eriksson UJ and Fredén M: Maternal diabetes in the rat enhances the transfer of glucose to the early embryo. Diabetes Res Clin Pract 5 (Suppl 1): S453, 1988 (Abstract). 94 Weigensberg MJ, Garcia-Palmer FJ, and Freinkel N: Uptake of myo-inositol by early-somite rat conceptus. Transport kinetics and effects of hyperglycemia. Diabetes 39: 575–582, 1990. 95 Pinter E, Reece EA, Ogburn PL, Turner S, Hobbins JC, Mahoney MJ, and Naftolin F: Fatty acid content of yolk sac and embryo in hyperglycemia-induced embryopathy and effect of arachidonic acid supplementation. Am J Obstet Gynecol 159: 1484–1490, 1988. 96 Engström E, Haglund Å, and Eriksson UJ: Effects of maternal diabetes or in vitro hyperglycemia on uptake of plamitic and arachidonic acid by rat embryos. Pediatr Res 30: 150–153, 1991. 97 Hunter ES, and Sadler TW: The role of the visceral yolk sac in hyperglycemia-induced embryopathics in mouse embryos in vitro. Teratology 45: 195–203, 1992. 98 Eriksson UJ, Dahlström VE, and Lithell HO: Diabetes in pregnancy: influence of genetic background and maternal diabetic state on the incidence of skeletal malformations in the fetal rat. Acta Endocrinol (Copenhagen) 112 (Suppl 277): 66–73, 1986. 99 Vercheval M, De Hertogh R, Pampfer S, Vanderheyden I, Michiels B, De Bernardi P, and De Meyer R: Experimental diabetes impairs rat embryo development during the preimplantation period. Diabetologia 33: 187–191, 1990. 100 Beebe LFS, and Kaye PL: Maternal diabetes and retarded preimplantation development of mice. Diabetes 40: 457–461, 1991. 101 Moley KH, Vaughn WK, DeCherney AH, and Diamond MP: Effect of diabetes mellitus on mouse pre-implantation embryo development. J Reprod Fertil 93: 325–332, 1991. 102 Zusman I, Ornoy A, Yaffe P, and Shafrir E: Effects of glucose and serum from streptozotocin-diabetic and non-diabetic rats on the in vitro development of preimplantation mouse embryos. Isr J Med Sci 21: 359–365, 1985. 103 Diamond MP, Harbert-Moley K, Logan J, Pellicer A, Lavy G, Vaughn WK, and DeCherney AH: Manifestation of diabetes mellitus on mouse follicular and pre-embryo development: effects of hyperglycemia per se. Metabolism 39: 220–224, 1990. 104 De Hertogh R, Vanderheyden I, Pampfer S, Robin D, Dufrasne E, and Delcourt J: Stimulatory and inhibitory effects of glucose and insulin on rat blastocyst development in vitro. Diabetes 40: 641–647, 1991. 105 Zusman I, Yaffe P, and Ornoy A: Effects of metabolic factors in the diabetic state on the in vitro development of preimplantation mouse embryos. Teratology 35: 77–85, 1987. 106 Moley KH, Vaughn WK, and Diamond MP: Manifestations of diabetes mellitus on mouse preimplantation development: effect of elevated concentration of metabolic intermediates. Hum Reprod 9: 113–121, 1994. 107 Rao LV, Wikarczuk ML, and Heyner S: Functional roles of insulin and insulin-like growth factors in preimplantation mouse embryo development. In Vitro Cell Dev Biol 26: 1043–1048, 1990. 108 Baroffio A, Raddatz E, Markert M, and Kucera P: Transient stimulation of glucose metabolism by insulin in the 1-day chick embryo. J Cell Physiol 127: 288–292, 1986. 109 Harvey MB, and Kaye PL: Insulin stimulates protein synthesis in compacted mouse embryos. Endocrinology 122: 1182–1184, 1988. 110 Wales RG, Khurana NK, Edirisinghe WR, and Pike IL: Metabolism of glucose by preimplantation mouse embryos in the presence of glucagon insulin epinephrine cAMP theophyl-line and caffeine. Aust J Biol Sci 38: 421–428, 1985. 111 Caro CM, and Trounson A: The effect of protein on preimplantation mouse development in vitro. J In Vitro Fertil Embryo Trans 1: 183–187, 1984. 112 Gardner DK, and Kaye PL: Insulin increases cell number and morphological development in mouse preimplantation embryos in vitro. Reprod Fertil Dev 3: 79–91, 1991. 113 Zhang X, and Armstrong DT: Presence of amino acids and insulin in a chemically defined medium improves development of 8-cell rat embryos in vitro and subsequent implantation in vivo. Biol Reprod 15: 662–668, 1990. 114 Harvey MB, and Kaye PL: Insulin increases the cell number of the inner cell mass and stimulates morphological development of mouse blastocysts in vitro. Development 110: 963–967, 1990. 115 Estrada JL, Jones EE, Johnson BH, and Petters RM: Effect of insulin-like growth factor-I on protein synthesis in porcine embryonic discs cultured in vitro. J Reprod Fertil 93: 53–61, 1991. 116 Girbau M, Bassas L, Alemany J, and De Pablo F: In situ autoradiography and ligand-dependent tyrosine kinase activity reveal insulin receptors and insulin-like growth factor I receptors in prepancreatic chicken embryos. Proc Natal Acad Sci USA 86: 5368–5372, 1989. 117 Kikuchi K, Buonomo FC, Kajimoto Y, and Rotwein P: Expression of insulin-like growth factor-I during chicken development. Endocrinology 128: 153–158, 1991. 118 Diamond MP, Pettway ZY, Logan J, Moley K, Vaughn W, and DeCherney AH: Dose–response effects of glucose, insulin and glucagon on mouse pre-embryo development. Metabolism 40: 566–570, 1991. 119 Hogan A, Heyner S, Charron MJ, Copeland NG, Gilbert DJ, Jenkins NA, Thorens B, and Schultz GA.: Glucose transporter gene expression in early mouse embryos. Development 113: 93–102, 1991. 120 Baltz JM, Biggers JD, and Lechene C: Two-cell stage mouse embryos appear to lack mechanisms for alleviating intracellular acid loads. J Biol Chem 266: 6052–6057, 1991. 121 Sadler TW: Langman's Medical Embryology, 5th ed. Williams & Wilkins, Baltimore, 1985. 122 Sulik KH, and Johnston MC: Sequence of developmental alterations following acute ethanol exposure in mice: craniofacial features of the fetal alcohol syndrome. Am J Anat 166: 257–269, 1983. 123 Miki A, Fujimoto E, Ohsai T, and Mizoguti H: Effects of oxygen concentration on embryonic development in rats: a light and electron microscopic study using whole-embryo culture techniques. Anat Embryol 178: 337–343, 1988. 124 Shepard TH, Tanimura T, and Robkin MA: Energy metabolism in early mammalian embryos. Dev Biol (Suppl) 4: 42–58, 1970. 125 Hunter ES, and Sadler TW: Metabolism of d- and dl-β-hydroxybutyrate by mouse embryos in vitro. Metabolism 36: 558–561, 1987. 126 Clough JR, and Whittingham DG: Metabolism of [14C]glucose by postimplantation mouse embryos in vitro. J. Embryol Exp Morphol 74: 133–142, 1983. 127 Hunter ES, and Sadler TW: Embryonic metabolism of foetal fuels in whole-embryo culture. Toxic In Vitro 2: 163–167, 1988. 128 Neubert D: Aerobic glycolysis in mammalian embryos. In Metabolic Pathways in Mammalian Embryos During Organogenesis and its Modification by Drugs, R Bass, F Beck, HJ Merker, D Neubert, and B Randhahn, Eds. Freie Universität Berlin, Berlin, 1971, pp. 225–248. 129 Mackler B, Grace R, and Duncan HM: Studies of mitochondrial development during embryogenesis in the rat. Arch Biochem Biophys 144: 603–610, 1971. 130 Goodman SI, Stene DO, McCabe ER, Norenberg MD, Shikes RH, Stumpf DA, and Blackburn GK: Glutaric acidemia type II: clinical, biochemical and morphologic considerations. J Pediatr 100: 946–950, 1982. 131 Brown GK, Hunt SM, Scholem R, Fowler K, Grimes A, Mercer JFB, Truscott RM, Cotton RGH, Rogers JG, and Danks DM: β-Hydroxybutyryl coenzyme A deacylase deficiency: a defect in valine metabolism associated with physical malformations. Pediatrics 70: 532–538, 1982. 132 Bargman GJ, Mackler B, and Shepard TH: Studies of oxidative energy deficiency. I. Achondroplasia in the rabbit. Arch Biochem Biophys 150: 137–146, 1972. 133 Fantel AG, Juchau MR, Burroughs CJ, and Person RE: Studies of embryotoxic mechanisms of niridazole: evidence that oxygen depletion plays a role in dysmorphogenicity. Teratology 39: 243–251, 1989. 134 Fantel AG, Person RE, Burroughs-Gleim CJ, Shepard TH, Juchau MR, and Mackler B: Asymmetric development of mitochondrial activity in rat embryos as determinants of the defect patterns induced by exposure to hypoxia, hyperoxia and redox cyclers in vitro. Teratology 44: 355–362, 1991. 135 Fantel AG, Person RE, Burroughs-Gleim CJ, and Mackler B: Direct embryotoxicity of cocaine in rats: effects on mitochondrial activity, cardiac function, and growth and development in vitro. Teratology 42: 8–16, 1990. 136 Akazawa S, Akazawa M, Hashimoto M, Yamaguchi Y, Kuriya N, Toyama K, Ueda Y, Nakanishi T, Mori T, Miyake S, and Nagataki S: Effects of hypoglycaemia on early embryogenesis in rat embryo organ culture. Diabetologia 30: 791–796, 1987. 137 Buchanan TA, Schemmer JK, and Freinkel N: Embryotoxic effects of brief maternal insulin-hypoglycemia during organogenesis in the rat. J Clin Invest 78: 643–649, 1986. 138 Cagliero E, Forsberg H, Sala R, Lorenzi M, and Eriksson UJ: Maternal diabetes induces increased expression of extracellular matrix components in rat embryos. Diabetes 42: 975–980, 1993. 139 Unger E, and Eriksson UJ: Regionally disturbed production of cartilage proteoglycans in malformed fetuses from diabetic rats. Diabetologia 35: 517–521, 1992. 140 Cockroft DL, and Coppola PT: Teratogenic effects of excess glucose on head-fold rat embryos in culture. Teratology 16: 141–146, 1977. 141 Sadler TW: Effects of maternal diabetes on early embryogenesis. II: Hyperglycemia-induced exencephaly. Teratology 21: 349–356, 1980. 142 Hor
Referência(s)